Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

Join us for an informative webinar on creating induced pluripotent stem cells (iPSCs), which sheds light on the strengths of the mRNA technique compared to other methods.

Discover the new Miltenyi Biotec mRNA reprogramming workflow and its myriad of benefits including enhanced efficiency, safety, and reproducibility in a streamlined process that ensures high-quality iPSCs.

Hannah Johannsen and Parivash Nouri (Miltenyi Biotec) will provide a comprehensive overview of the entire reprogramming workflow — from fibroblast collection to iPSC generation, isolation, and quality control.

Sebastian Diecke (Max Delbrück Center, Berlin) will showcase outcomes achieved in his lab through the application of the technique.

• Understand each step within the reprogramming workflow
• Learn how to optimize your reprogramming experiments
• Gain practical insights into reprogramming or iPSC generation from first-hand experience

Sebastian Diecke

Stem Cell Core Director at Max Delbrück Center For Molecular Medicine

Dr Sebastian Diecke is working as a head of the Pluripotent Stem cell Platform at the Max Delbrück Center in Berlin. His research involves reprogramming, differentiation, and genome editing of human induced pluripotent stem cells (hiPSCs).

Hannah Johannsen

Group Leader & Project Manager, R&D, Molecular Technologies & Stem Cell Therapy at Miltenyi Biotec

Hannah Johannsen has been with Miltenyi Biotec B.V. & Co.KG for 10 years and currently holds the position of a Group Lead in the R&D department with a focus on iPSC-technologies and cell sorting.

Parivash Nouri

Global Product Manager for Pluripotent Stem Cells in Research at Miltenyi Biotec

During her PhD, Parivash conducted research on iPSCs and their differentiation into midbrain dopaminergic neurons. Currently, she holds the position of Application Product Manager for Pluripotent Stem Cells in research within the Global Marketing department.

Watch now

SPEAKERS

Sebastian Diecke

Stem Cell Core Director at Max Delbrück Center For Molecular Medicine

Hannah Johannsen

Group Leader & Project Manager, R&D, Molecular Technologies & Stem Cell Therapy at Miltenyi Biotec

Parivash Nouri

Global Product Manager for Pluripotent Stem Cells in Research at Miltenyi Biotec

You might also like

Process optimization of mRNA purification for vaccines and therapeutic applications

Chantelle Gaskin

13 June

Watch

Scalable chromatographic strategies for mRNA and saRNA purification from IVT

Tomas Kostelec

29 February

Watch

Precise mRNA purity assessment for accelerated therapeutic development and release testing

Paul Mania, Joe Ferraiolo

19 September

Watch

Unlocking mRNA-LNP potential using a novel lipid library combined with innovative analytical methods

Nejc Pavlin, Guillaume Freund

11 September

Watch